Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam L Halberstadt

Showing results (11-20 of 89) with videos related to

Pageof 9
Sort By:
Neuropharmacology|September 10, 2013
Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch responseAdam L Halberstadt, Mark A Geyer
Journal of Chemical Neuroanatomy|April 25, 2008
Selective anterograde tracing of nonserotonergic projections from dorsal raphe nucleus to the basal forebrain and extended amygdalaAdam L Halberstadt, Carey D Balaban
Psychopharmacology|February 15, 2013
Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movementAdam L Halberstadt, Mark A Geyer
Psychopharmacology|November 26, 2009
LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptorAdam L Halberstadt, Mark A Geyer
Neuropharmacology|April 16, 2026
MICRODOSING: FACT OR FICTION?Adam L Halberstadt, Jared W Young
Psychopharmacology|January 7, 2012
Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitorAdam L Halberstadt, David E Nichols, Mark A Geyer
Neuropharmacology|February 5, 2013
Role of the 5-HT₂A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in miceAdam L Halberstadt, Susan B Powell, Mark A Geyer
Journal of Psychoactive Drugs|May 17, 2014
PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis ProgramGeorge R Greer, Charles S Grob, Adam L Halberstadt
The International Journal of Neuropsychopharmacology|October 11, 2015
BDNF-Deficient Mice Show Reduced Psychosis-Related Behaviors Following Chronic MethamphetamineElizabeth E Manning, Adam L Halberstadt, Maarten van den Buuse
Frontiers in Pharmacology|September 7, 2013
Hippocampal serotonin depletion unmasks differences in the hyperlocomotor effects of phencyclidine and MK-801: quantitative versus qualitative analysesWendy K Adams, Adam L Halberstadt, Maarten van den Buuse
Pageof 9

Showing results (11-20 of 89) with videos related to

Sort By:
Pageof 9
Neuropharmacology|September 10, 2013
Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch responseAdam L Halberstadt, Mark A Geyer
Journal of Chemical Neuroanatomy|April 25, 2008
Selective anterograde tracing of nonserotonergic projections from dorsal raphe nucleus to the basal forebrain and extended amygdalaAdam L Halberstadt, Carey D Balaban
Psychopharmacology|February 15, 2013
Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movementAdam L Halberstadt, Mark A Geyer
Psychopharmacology|November 26, 2009
LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptorAdam L Halberstadt, Mark A Geyer
Neuropharmacology|April 16, 2026
MICRODOSING: FACT OR FICTION?Adam L Halberstadt, Jared W Young
Psychopharmacology|January 7, 2012
Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitorAdam L Halberstadt, David E Nichols, Mark A Geyer
Neuropharmacology|February 5, 2013
Role of the 5-HT₂A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in miceAdam L Halberstadt, Susan B Powell, Mark A Geyer
Journal of Psychoactive Drugs|May 17, 2014
PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis ProgramGeorge R Greer, Charles S Grob, Adam L Halberstadt
The International Journal of Neuropsychopharmacology|October 11, 2015
BDNF-Deficient Mice Show Reduced Psychosis-Related Behaviors Following Chronic MethamphetamineElizabeth E Manning, Adam L Halberstadt, Maarten van den Buuse
Frontiers in Pharmacology|September 7, 2013
Hippocampal serotonin depletion unmasks differences in the hyperlocomotor effects of phencyclidine and MK-801: quantitative versus qualitative analysesWendy K Adams, Adam L Halberstadt, Maarten van den Buuse
Pageof 9